News | March 02, 2015

First Patient Treatment Completed with CyberKnife M6 System and InCise Multileaf Collimator

Treatment time for patient with brain tumor reduced from one hour to 22 minutes

Accuray, CyberKnife M6, InCise, MLC, collimator, radiation therapy, UPMC, first

March 2, 2015 — Accuray Inc. announced that the first patient treatment has been completed using the CyberKnife M6 System with the InCise Multileaf Collimator (MLC). The treatment was administered as a multidisciplinary effort between Steven Burton, M.D., from the Department of Radiation Oncology, and Johnathan Engh, M.D., from the Department of Neurosurgery at the University of Pittsburgh Medical Center (UPMC) in Pittsburgh, Pennsylvania. UPMC was one of the InCise MLC evaluation sites working in collaboration with Accuray.

"We have successfully treated the first patient using the CyberKnife M6 System with the InCise MLC. The patient, diagnosed with a brain meningioma, was a typical candidate for highly-focused treatment that can be delivered by the CyberKnife," said Dwight E. Heron, M.D., FACRO, FACR, director of radiation services. "With the addition of the MLC, we were able to achieve equivalent precision in tumor targeting and sparing of healthy tissue, but it took us less than half the time – just under 22 minutes – to complete a traditional one-hour treatment. The treatment time includes continuous imaging throughout the procedure to ensure accurate dose delivery and the actual time spent delivering the radiation. This real-world case is consistent with our InCise MLC technical evaluation experience and exceeded our expectations in its efficiency."  

The M6 Series delivers radiosurgery and stereotactic body radiation therapy, enabling precise, high-quality dose distributions to the patient with extreme accuracy over a minimum number of treatments, reducing side effects and preserving patients' quality of life. The system is able to adjust and automatically stay on target in real-time, accounting for patient and tumor motion.

For more information: www.accuray.com

Related Content

Noninvasive Radioablation Offers Long-term Benefits to High-risk Heart Arrhythmia Patients
News | Radiation Therapy | September 17, 2019
September 17, 2019 — Treating high-risk heart patients with a single, high dose of...
Sun Nuclear Presents Portfolio of Independent Radiotherapy QA Solutions at ASTRO 2019

The PlanCheck module now part of SunCheck, automates plan quality checks, validates treatment plans against requirements, and automatically assesses plan performance versus intent.

News | Quality Assurance (QA) | September 16, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) Annual Meeting, running Sept. 15-18 in Chicago, Sun Nuclear...
Varian Unveils Ethos Solution for Adaptive Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | September 16, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian...
Long-term Hormone Therapy Increases Mortality Risk for Low-PSA Men After Prostate Surgery
News | Prostate Cancer | September 16, 2019
Secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer...
The Siemens Somatom Go.Sim computed tomography (CT) system for dedicated radiation therapy planning

The Siemens Somatom Go.Sim computed tomography (CT) system for dedicated radiation therapy planning. Image courtesy of Siemens Healthineers.

News | Computed Tomography (CT) | September 15, 2019
Siemens Healthineers debuted two computed tomography (CT) systems dedicated to radiation therapy (RT) planning at the...
Isoray to Spotlight Cesium-131 Advances at ASTRO Annual Meeting
News | Brachytherapy Systems | September 13, 2019
Isoray Inc. announced it will spotlight the growing cancer treatment applications of Cesium-131 brachytherapy at the...
Akesis Galaxy SRS System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | September 13, 2019
The Akesis Galaxy, a gamma stereotactic radiosurgery system (SRS) with continuous 360-degree rotational technology, has...
Philips Showcases Integrated Radiation Oncology Portfolio at ASTRO 2019
News | Radiation Oncology | September 13, 2019
Philips will showcase its integrated radiation oncology portfolio at the American Society of Radiation Oncology (ASTRO...
RefleXion Highlights Novel Approach to Radiotherapy at ASTRO 2019

The RefleXion X1 Machine without the Gantry Cover. The patented technology incorporates PET imaging data, which enables tumors to continuously signal their location. Image courtesy of Reflexion Medical.

News | Radiation Therapy | September 12, 2019
Therapeutic oncology company RefleXion Medical announced it will showcase the RefleXion X1 Machine at the American...
IBA Dosimetry Releases myQA Machines Software at ASTRO 2019
Technology | Quality Assurance (QA) | September 12, 2019
IBA Dosimetry GmbH announced the launch of the new enhanced myQA Machines 2019 software environment at the upcoming...